(Q37611121)

21 August 2017

1 reference

title

Quality of different chondroitin sulfate preparations in relation to their therapeutic activity (English)

1 reference

21 August 2017

Nicola Volpi

1

0 references

publication date

1 October 2009

1 reference

Journal of Pharmacy and Pharmacology

21 August 2017

published in

1 reference

21 August 2017

volume

61

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

1271-1280

1 reference

Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with a neurite outgrowth promoting activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Therapeutic applications of glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Advances in chondroitin sulfate analysis: application in physiological and pathological States of connective tissue and during pharmacological treatment of osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Potential therapeutic application of chondroitin sulfate/dermatan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Chondroitin sulfate as a structure-modifying agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Clinical review of chondroitin sulfate in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Potential effects of chondroitin sulfate on joint swelling: a GAIT report

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Chicken keel cartilage as a source of chondroitin sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Analytical aspects of pharmaceutical grade chondroitin sulfates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

Absence of detectable infectivity in trachea of BSE-affected cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0002

21 January 2018

Identifiers

DOI

10.1211/JPP.61.10.0002

1 reference

21 August 2017

1 reference